Bim expression is reduced in human cutaneous melanomas

被引:37
作者
Dai, Derek L. [1 ]
Wang, Yemin [1 ]
Liu, Min [1 ]
Martinka, Magdalena [2 ]
Li, Gang [1 ]
机构
[1] Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1038/sj.jid.5700989
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Bim is a BH3-only protein belonging to the Bcl-2 family of apoptotic regulators. Upon activation, Bim can antagonize all the prosurvival Bcl-2 proteins, leading to apoptosis. To investigate whether Bim plays a role in melanoma progression, we used tissue microarray and immunohistochemistry to measure Bim expression in 52 cases of dysplastic nevi, 159 cases of primary melanomas and 52 cases of melanoma metastases, and evaluated the prognostic value of Bim expression. Our results showed that Bim expression is reduced as melanoma progresses. Significant differences for Bim staining pattern were observed between dysplastic nevi and metastatic melanomas (P < 0.001, chi(2) test), and between primary melanomas and metastatic melanomas (P < 0.001, chi(2) test). Moreover, reduced Bim expression is significantly correlated with poor 5-year survival of melanoma patients but failed to be an independent prognostic factor by Cox regression analysis. Our data suggest that Bim loss may play an important role in melanoma progression.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 46 条
[31]   Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma [J].
Panka, DJ ;
Atkins, MB ;
Mier, JW .
CLINICAL CANCER RESEARCH, 2006, 12 (07) :2371S-2375S
[32]   JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis [J].
Putcha, GV ;
Le, SY ;
Frank, S ;
Besirli, CG ;
Clark, K ;
Chu, BY ;
Alix, S ;
Youle, RJ ;
LaMarche, A ;
Maroney, AC ;
Johnson, EM .
NEURON, 2003, 38 (06) :899-914
[33]   The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex [J].
Puthalakath, H ;
Huang, DCS ;
O'Reilly, LA ;
King, SM ;
Strasser, A .
MOLECULAR CELL, 1999, 3 (03) :287-296
[34]  
REMMELE W, 1987, PATHOLOGE, V8, P138
[35]   The incidence of malignant melanoma in the United States: Issues as we approach the 21st century [J].
Rigel, DS ;
Friedman, RJ ;
Kopf, AW .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (05) :839-847
[36]   The effect of sunscreen on melanoma risk [J].
Rigel, DS .
DERMATOLOGIC CLINICS, 2002, 20 (04) :601-+
[37]   Structure of Bcl-x(L)-Bak peptide complex: Recognition between regulators of apoptosis [J].
Sattler, M ;
Liang, H ;
Nettesheim, D ;
Meadows, RP ;
Harlan, JE ;
Eberstadt, M ;
Yoon, HS ;
Shuker, SB ;
Chang, BS ;
Minn, AJ ;
Thompson, CB ;
Fesik, SW .
SCIENCE, 1997, 275 (5302) :983-986
[38]  
Serrone L, 2000, J EXP CLIN CANC RES, V19, P21
[39]   A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? [J].
Smalley, KSM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) :527-532
[40]  
Smith L, 2006, ONCOL RES, V15, P441